Last week, the U.S. Food and Drug Administration (FDA) approved the second of a new wave of molecularly targeted therapeutics that can be used to treat patients with any type of cancer provided their...
Cervical cancer patients may benefit from addressing any stress disorders they might have, as it could potentially improve their cancer prognosis.
The AACR Project Genomics Evidence Neoplasia Information Exchange (AACR Project GENIE) is a unique registry that aggregates, harmonizes, and links clinical-grade cancer genomic data with clinical outcomes from tens of thousands of cancer patients....
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib (Piqray), polatuzumab vedotin-piiq (Polivy), selinexor (Xpovio), and darolutamide (Nubeqa)—for treating certain patients with a wide...
Cancer is very complex, and the tools that we need to understand how it develops and progresses come from many different scientific fields. Integrative Molecular Epidemiology, known as IME, brings together epidemiologists, data scientists,...
As a monthly staple on this blog, we feature the editors’ picks from the 10 journal issues published by the American Association for Cancer Research (AACR). This month, selections include two articles detailing laboratory...
A study found that exposure to World Trade Center dust may alter inflammatory pathways, leading to the progression of prostate cancer.
This spring, in the inaugural year of the American Association for Cancer Research (AACR) Global-Scholar-In-Training Awards (GSITA) program, 15 young researchers from around the world arrived in Atlanta eager to share their knowledge and...
Understanding brain metastasis risk could influence screening, surveillance practices, a study of breast cancer, lung cancer, and melanoma patients found.
Since 2011, immunotherapy has emerged as an exciting new approach to cancer treatment that is yielding unprecedented, durable responses for patients with an increasingly diverse array of cancer types. Much of the excitement has...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More